v-Crk Modulation of Growth Factor-induced PC12 Cell Differentiation Involves the Src Homology 2 Domain of v-Crk and Sustained Activation of the Ras/Mitogen-activated Protein Kinase Pathway
Open accessThe DOI matches its Crossref record; 2 of the 2 references it cites were found in a registry or an index.
Abstract
Nerve growth factor (NGF) and epidermal growth factor (EGF) elicit contrasting actions on PC12 pheochromocytoma cells; NGF causes neuronal differentiation, and EGF induces proliferation. However, ectopic expression of the Src homology 2 (SH2) and SH3-containing oncogenic adaptor protein v-Crk in PC12 cells results in EGF-inducible neuronal differentiation (Hempstead, B. L., Birge, R. B., Fajardo, J. E., Glassman, R., Mahadeo, D., Kraemer, R., and Hanafusa, H. (1994) Mol. Cell. Biol. 14, 1964-1971). Here we show that v-Crk complexes with both the tyrosine-phosphorylated EGF receptor and the Ras guanine nucleotide exchange factor SOS in PC12 cells and is involved in an pathway analogous to that of Grb2. Expression of v-Crk results in an enhanced and sustained activation of Ras and mitogen-activated protein (MAP) kinase following EGF or NGF stimulation, implying that v-Crk can couple divergent tyrosine kinase pathways to Ras. To investigate the causal relationship between EGF receptor binding, MAP kinase activation, and neurite outgrowth, we stably expressed two v-Crk SH2 point mutants, v-Crk(R273N) and v-Crk(H294R) in PC12 cells. Mutations within the SH2 domain of v-Crk block binding of v-Crk to the tyrosine phosphorylated EGF receptor, compromise v-Crk's ability to cause EGF-dependent neurite outgrowth, and act in a dominant negative manner for NGF-induced neurite outgrowth. However, the kinetics of MAP kinase activation in EGF- or NGF-treated v-Crk-(R273N)PC12 cells was comparable with that in v-CrkPC12 cells. These data are consistent with a model in which v-Crk regulates the strength of a tyrosine kinase signal leading to prolonged activation of Ras and MAP kinase. However, the experiments with the SH2 mutants suggest that sustained activation, by itself, may not be sufficient to switch the fate of v-CrkPC12 cells from proliferation toward differentiation.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Signal transduction by receptors with tyrosine kinase activity
Ullrich, A., & Schlessinger, J. (1990) · Cell · doi:10.1016/0092-8674(90)90801-k · Cited by 5,435
The trk Proto-Oncogene Product: a Signal Transducing Receptor for Nerve Growth Factor
Kaplan, D. R., Hempstead, B. L., Martin-Zanca, D., Chao, M. V., & Parada, L. F. (1991) · Science · doi:10.1126/science.1850549 · Cited by 1,379
Self-citation
Research works printed but not linked: 52
- Cantley, 1991, Cell, 64, 281, 10.1016/0092-8674(91)90639-G · DOI · Paper page
- Fantl, 1993, Annu. Rev. Biochem., 62, 453, 10.1146/annurev.bi.62.070193.002321 · DOI · Paper page
- Pazin, 1992, Trends Biochem. Sci., 17, 374, 10.1016/0968-0004(92)90003-R · DOI · Paper page
- Pawson, 1992, Cell, 71, 359, 10.1016/0092-8674(92)90504-6 · DOI · Paper page
- Margolis, 1992, Cell Growth & Differ., 3, 73
- Mayer, 1993, Trends Cell Biol., 3, 8, 10.1016/0962-8924(93)90194-6 · DOI · Paper page
- Birge, 1993, Science, 262, 1522, 10.1126/science.7504323 · DOI
- Greene, 1976, Proc. Natl. Acad. Sci. U. S. A., 73, 2424, 10.1073/pnas.73.7.2424 · DOI · Paper page
- Greene, 1982, Adv. Cell. Neurobiol., 3, 373, 10.1016/B978-0-12-008303-9.50016-5 · DOI · Paper page
- Chao, 1992, Cell, 68, 995, 10.1016/0092-8674(92)90068-N · DOI · Paper page
- Qui, 1991, Neuron, 7, 937, 10.1016/0896-6273(91)90339-2 · DOI
- Traverse, 1992, Biochem. J., 288, 351, 10.1042/bj2880351 · DOI · Paper page
- Cowley, 1994, Cell, 77, 841, 10.1016/0092-8674(94)90133-3 · DOI · Paper page
- Traverse, 1994, Curr. Biol., 4, 694, 10.1016/S0960-9822(00)00154-8 · DOI · Paper page
- Dikic, 1994, Curr. Biol., 4, 702, 10.1016/S0960-9822(00)00155-X · DOI · Paper page
- Noda, 1985, Nature, 318, 73, 10.1038/318073a0 · DOI · Paper page
- Heasley, 1992, Mol. Cell. Biol., 3, 545, 10.1091/mbc.3.5.545 · DOI · Paper page
- Rozakis-Adcock, 1992, Nature, 360, 689, 10.1038/360689a0 · DOI · Paper page
- Wood, 1993, Proc. Natl. Acad. Sci. U. S. A., 90, 5016, 10.1073/pnas.90.11.5016 · DOI · Paper page
- Mayer, 1988, Nature, 332, 272, 10.1038/332272a0 · DOI · Paper page
- Matsuda, 1990, Science, 248, 1537, 10.1126/science.1694307 · DOI · Paper page
- Hempstead, 1994, Mol. Cell. Biol., 14, 1964, 10.1128/MCB.14.3.1964 · DOI
- Wang, 1985, Mol. Cell. Biol., 5, 3640, 10.1128/MCB.5.12.3640 · DOI
- Potts, 1987, J. Gen. Virol., 68, 3177, 10.1099/0022-1317-68-12-3177 · doi:10.1099/0022-1317-68-12-3177
- Mayer, 1990, J. Virol., 64, 3581, 10.1128/JVI.64.8.3581-3589.1990 · DOI
- Willumsen, 1991, Mol. Cell. Biol., 11, 6026, 10.1128/MCB.11.12.6026 · DOI
- Hall, 1983, J. Mol. Appl. Genet., 2, 101
- Rosenthal, 1987, Methods Enzymol., 152, 704, 10.1016/0076-6879(87)52075-4 · DOI · Paper page
- Loeb, 1992, Neuron, 9, 1053, 10.1016/0896-6273(92)90065-L · DOI
- Downward, 1991, Nature, 246, 719
- Waksman, 1993, Cell, 72, 779, 10.1016/0092-8674(93)90405-F · DOI · Paper page
- Marengere, 1992, J. Biol. Chem., 267, 22779, 10.1016/S0021-9258(18)50015-6 · doi:10.1016/s0021-9258(18)50015-6
- Gout, 1993, Cell, 75, 25, 10.1016/S0092-8674(05)80081-9 · doi:10.1016/s0092-8674(05)80081-9 · Paper page
- Feller, 1994, EMBO J., 13, 2341, 10.1002/j.1460-2075.1994.tb06518.x · DOI · Paper page
- Rozakis-Adcock, 1993, Nature, 363, 83, 10.1038/363083a0 · DOI · Paper page
- Gale, 1993, Nature, 363, 88, 10.1038/363088a0 · DOI · Paper page
- Egan, 1993, Nature, 363, 45, 10.1038/363045a0 · DOI · Paper page
- Tanaka, 1994, Proc. Natl. Acad. Sci. U. S. A., 91, 3443, 10.1073/pnas.91.8.3443 · DOI · Paper page
- Hagag, 1986, Nature, 319, 680, 10.1038/319680a0 · DOI · Paper page
- Feig, 1988, Mol. Cell. Biol., 8, 2472, 10.1128/MCB.8.6.2472 · DOI · Paper page
- Hashimoto, 1994, Oncogene, 9, 869
- Cherniack, 1994, J. Biol. Chem., 269, 4717, 10.1016/S0021-9258(17)37603-2 · DOI · Paper page
- Aronheim, 1994, Cell., 78, 949, 10.1016/0092-8674(94)90271-2 · DOI · Paper page
- Kremer, 1991, J. Cell Biol., 115, 809, 10.1083/jcb.115.3.809 · DOI · Paper page
- D'Arcangelo, 1993, Mol. Cell. Biol., 13, 3146, 10.1128/MCB.13.6.3146 · DOI · Paper page
- Wood, 1992, Cell, 68, 1041, 10.1016/0092-8674(92)90076-O · DOI · Paper page
- Suen, 1993, Mol. Cell. Biol., 13, 5500, 10.1128/MCB.13.9.5500 · DOI
- Obermeier, 1994, EMBO J., 13, 1585, 10.1002/j.1460-2075.1994.tb06421.x · DOI · Paper page
- Sasaoka, 1994, J. Biol. Chem., 269, 32621, 10.1016/S0021-9258(18)31679-X · DOI · Paper page
- Tanaka, 1993, Mol. Cell. Biol., 13, 4409, 10.1128/MCB.13.7.4409 · DOI · Paper page
- Levi, 1991, Annu. Rev. Pharmacol. Toxicol., 31, 205, 10.1146/annurev.pa.31.040191.001225 · DOI · Paper page
- Campenot, 1994, J. Neurobiol., 25, 599, 10.1002/neu.480250603 · DOI · Paper page
Cited by
Signal transduction by reactive oxygen species
Finkel, T. (2011) · Journal of Cell Biology · doi:10.1083/jcb.201102095 · Cited by 2,322
Emergent Properties of Networks of Biological Signaling Pathways
Bhalla, U. S., & Iyengar, R. (1999) · Science · doi:10.1126/science.283.5400.381 · Cited by 1,686
Nerve Growth Factor Signaling, Neuroprotection, and Neural Repair
Sofroniew, M. V., Howe, C. L., & Mobley, W. C. (2001) · Annual Review of Neuroscience · doi:10.1146/annurev.neuro.24.1.1217 · Cited by 1,284
Hydrogen Peroxide: A Signaling Messenger
Stone, J. R., & Yang, S. (2006) · Antioxidants & Redox Signaling · doi:10.1089/ars.2006.8.243 · Cited by 1,172
REGULATION OF GENE EXPRESSION BY REACTIVE OXYGEN
Dalton, T. P., Shertzer, H. G., & Puga, A. (1999) · Annual Review of Pharmacology and Toxicology · doi:10.1146/annurev.pharmtox.39.1.67 · Cited by 1,118
Metadata
- Authors
- Teng, K. K., Lander, H., Fajardo, J. E., Hanafusa, H., Hempstead, B. L., & Birge, R. B.
- Venue
- Journal of Biological Chemistry
- Publisher
- Elsevier BV
- Published
- 1995-09
- Volume
- 270
- Issue
- 35
- Pages
- 20677-20685
- ISSN
- 0021-9258 (ISSN-L)
- OpenAlex
- W2042971206
- Cited by
- 148
- References
- 2
- FWCI
- 5.09
- Type
- journal article
- Language
- en
- Open access
- hybrid
- Licence
- www.elsevier.com/tdm/userlicense/1.0/ (tdm)
- creativecommons.org/licenses/by/4.0/ (vor, 9210 d)
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.